Intrauterine Contraceptive Devices Market How The Market Will Witness Substantial Growth in the Upcoming years | Bayer HealthCare AG, Melbea AG, DKT International

Intrauterine contraceptive devices are a long-acting method of birth control.

In order to prevent pregnancy, Intrauterine Contraceptive Devices (IUDs) are inserted into the uterus. Typically shaped like a T, the arms of the device fold flat for insertion and it is designed to fit properly in the womb, with a size similar to a matchstick. IUDs are available with either copper or levonorgestrel, which can prevent fertilization by making it difficult for sperm to fertilize the egg. These devices are a form of long-acting reversible contraceptives (LARC) and provide effective birth control for an extended period of time, generally lasting between 5 to 8 years. IUDs are cost-effective and have a high level of satisfaction among users of reversible contraceptives. Copper IUDs can also be used as an emergency contraceptive after unprotected sex. When inserted immediately after delivery or abortion, IUDs do not have a negative impact on breastfeeding. Fertility returns to normal once the device is removed. Healthcare professionals are responsible for inserting IUDs. According to an article from Patient, a web-based health information platform, IUDs are highly effective, with only 1 to 2 out of every 100 women becoming pregnant after 5 years of use. In contrast, 80 out of 100 sexually active women who do not use this device become pregnant within one year.

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/53

Unplanned pregnancy is a major driver for intrauterine contraceptive devices

The demand for intrauterine contraceptive devices (IUDs) is being driven by several factors, including the increasing prevalence of unplanned pregnancy and the relatively low incidence of side effects associated with their use. One advantage of IUDs is that they do not require daily attention, unlike contraceptive pills. Additionally, IUDs do not appear to affect the user’s mood, libido, weight, or increase the risk of future cancer. However, the use of IUDs may lead to heavy menstrual bleeding and painful cramps, which could hinder market growth. Shorter-term usage of contraceptive pills may also compete with the demand for IUDs. Finally, the need for healthcare professionals to provide ongoing assistance with IUDs is also a factor limiting their market growth.

Hormonal IUCD has low failure rate as compared to copper IUD

The market for intrauterine contraceptive devices (IUDs) is segmented by product type into hormonal IUDs and copper IUDs. The failure rate for hormonal IUDs in the first year of use is approximately 0.2%, while the failure rate for copper IUDs is around 0.8%

In terms of end-use, IUDs are classified into hospital, gynecology clinics, and other settings. The market is further divided by geography, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The market for intrauterine contraceptive devices is expected to see a surge in demand in the Asia Pacific region.

The Asia Pacific region is projected to have a notable portion of the market for intrauterine contraceptive devices due to the increasing incidence of unplanned pregnancies and subsequent higher utilization of these devices in the region. Additionally, government initiatives that prioritize healthcare improvements in Asian countries are also driving the growth of the market. Furthermore, in North America and Europe, the demand for these devices is being amplified by technological advancements.

Leading companies involved in the production of intrauterine contraceptive devices include Bayer HealthCare AG, Melbea AG, DKT International, Medicines360, and Egemen International, among others. These companies are implementing strategic initiatives, such as mergers and acquisitions, to address the increasing demand from the target population. For example, in 2015, Bayer HealthCare partnered with Afaxys, Inc. to serve women in the United States. This partnership utilized Afaxys’ expertise and Bayer’s intrauterine device to serve the U.S. public health contraception market.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/53

Key Developments

The growth of the market is being propelled by a greater emphasis on women’s health and guidelines issued by regulatory authorities. For instance, in August 2019, the World Health Organization (WHO) updated its contraceptive use guidelines based on new evidence regarding the high risk of HIV in women. The revised guidelines advocate for women to have access to a variety of contraception options, as well as HIV prevention and treatment, including progestogen-only injectables, implants, and intrauterine devices (IUDs).

The adoption of promotion strategies and educational campaigns by major players in the market is expected to raise health awareness among consumers, leading to a surge in demand for IUDs. In February 2019, for example, Bayer HealthCare AG launched the first-ever advertising campaign focused on intrauterine devices (IUDs). The objective of the campaign was to educate people about the benefits of levonorgestrel-releasing IUDs and provide basic information about these devices.

Market players are implementing social marketing programs with an aim to provide family planning and HIV prevention solutions to women and couples in low and middle income countries. Such initiatives are driving the growth of the global intrauterine contraceptive devices market. In October 2018, DKT International’s Contraceptive Social Marketing (CSM) Statistics report highlighted that there has been a 6.8% increase in the sale of nearly 1.8 billion condoms, 44 million injectable contraceptives, nearly 1.4 million implants, over 17.3 million emergency contraception (EC) pills, and 5.1 million IUDs as compared to 2016. This represents an almost 18% increase in the sale of these products from 2015.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Intrauterine Contraceptive Devices Market Size Analysis from 2023 to 2028
11.6 COVID-19 Outbreak: Intrauterine Contraceptive Devices Industry Impact

Chapter 2 Global Intrauterine Contraceptive Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Intrauterine Contraceptive Devices (Volume and Value) by Type
2.3 Global Intrauterine Contraceptive Devices (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Intrauterine Contraceptive Devices Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Intrauterine Contraceptive Devices Market Analysis
Chapter 6 East Asia Intrauterine Contraceptive Devices Market Analysis
Chapter 7 Europe Intrauterine Contraceptive Devices Market Analysis
Chapter 8 South Asia Intrauterine Contraceptive Devices Market Analysis
Chapter 9 Southeast Asia Intrauterine Contraceptive Devices Market Analysis
Chapter 10 Middle East Intrauterine Contraceptive Devices Market Analysis
Chapter 11 Africa Intrauterine Contraceptive Devices Market Analysis
Chapter 12 Oceania Intrauterine Contraceptive Devices Market Analysis
Chapter 13 South America Intrauterine Contraceptive Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Intrauterine Contraceptive Devices Business
Chapter 15 Global Intrauterine Contraceptive Devices Market Forecast (2023-2030)
Chapter 16 Conclusions
Research Methodology